Evidence Reviews

Evidence reviews summarise the findings of a number of scientific research studies that have examined how well specific treatments work.

Environmental scans survey national and international industry sectors to identify current and emerging best practices in healthcare delivery.

Evidence reviews must be objective and not influenced by parties with vested interests. Evidence reviews can help providers and clients understand and predict the benefits that can be expected from a particular treatment. We use evidence reviews in its policy development and as a guide in decision making.

The evidence reviews listed below were conducted by the TAC and WorkSafe Evidence Service, a service provided between 2009 and June 2018 by the Institute for Safety Compensation and Recovery Research (ISCRR) based at Monash University.

From 1st July 2018, under the TAC's new research model, evidence reviews may be done internally by the TAC Research Branch or commissioned from one of our Research Panel providers. The Research Branch is independent from TAC business and client functions.

TAC has partnered with PEDro, the Physiotherapy Evidence Database. PEDro is a free database of randomised trials, systematic reviews and clinical practice guidelines in physiotherapy.

Recent evidence reviews:

Updated evidence reviews:

Implantable pain therapies

These include:

Intrathecal infusions include:

  • Opiates (opioids, narcotics)
  • Baclofen
  • Ziconotide

Neurostimulation includes:

Spinal injection therapies

These include:

Non-established, new or experimental treatment (NeNETS)

Lumbar Spinal Fusion

Evidence Reviews